International Partner Search

Innovation & Technology Offer

Surface modifications and coating technologies for the medical industry.

Country of Origin: Netherlands
Reference Number: TONL20181009001
Publication Date: 17 December 2018

Summary

A Dutch SME is a leading developer in the area of medical surface modifications. It's surfaces transform the performance of medical implants and devices for major medical device companies. The company has developed the only known surface that delivers true bone cell attachment for implanted devices cleared by the US Food and Drug Administration. The company is looking to expand business opportunities in the framework of commercial agreements with technical assitance.

Description

With over 25 years of surface modification experience, the Dutch company develops leading-edge surface technology for medical implant and other medical device applications. A number of proprietary surfaces and coatings that transform the performance of medical implants and devices have found their way into the medical market. The company has developed the only known surface that delivers true bone cell attachement, for  implanted devices cleared by the Food and Drug Administration (FDA-cleared). Other characteristics such as antimicrobial or fibroblast prevention can also be achieved using proprietary technologies.



The company offers its expertise to industrial and medical device manufacturers not only in surface modifications, but also in product development. With years of experience in bringing medical products to market, they can assist in in vitro and in vivo testing, as well as FDA approval. The company is looking for cooperation in the framework of  commercial agreements with technical assistance.

Advantages and Innovations

One such surface enhances bone cell attachment, not just ingrowth, to medical implants. It eliminates fibrolast formation around challenging polymers such as PEEK (polyetheretherketone) and generates true osteoblast attachment to a broad range of materials, whether solid or porous. 



Other capabilities are the deposition of antimicrobial surfaces, preventing biofilm formation on a broad range of interbody devices, such as access ports, pacemakers and surgical mesh. The antimicrobial performance can be tuned over time, which can be up to 9 months.

Stage Of Development

Already on the market

Requested partner

The company is looking to expand their business, primarily in the EU. Partners may be industrial and medical device companies who are looking for technological advances in developing new and existing medical devices. The company is looking for partnerships in the framework of commercial agreement with technical assistance, but are open to other forms of partnerships on request.

Dissemination Countries

Albania, Armenia, Austria, Bosnia and Herzegovina, Belgium, Bulgaria, Belarus, Switzerland, Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Greece, Croatia, Hungary, Ireland, Israel, Iceland, Italy, Lithuania, Luxembourg, Latvia, Moldova, Montenegro, Macedonia, The former Yugoslav Republic of, Malta, Netherlands, Norway, New Zealand, Poland, Portugal, Romania, Serbia, Russia, Sweden, Slovenia, Slovakia, Turkey, Ukraine, United Kingdom